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Abstract
Background
An evaluation study to determine the feasibility of integrating the Adolescent Diabetes Needs
Assessment Tool (ADNAT) App into UK paediatric diabetes care, to ascertain best practice 
standards, and to determine methodological recommendations for a future cohort study. 
Methods
A non-randomised,  cohort,  mixed methods study design was used to ensure equality of
access to ADNAT for all participants at three sites in the North West of England. Patients
who completed ADNAT (completers) were compared with those who failed to complete (non-
completers). Following UK Medical Research Council guidance, a logic model and the RE-
AIM (reach, effectiveness, adoption, implementation, maintenance) framework were used to
define study objectives. Patients’ glycaemic control (HbA1c) was accessed from their clinical
data at baseline and at 6 months, alongside their ADNAT scores which were correlated with
changes in HbA1c levels. The diabetes teams (respondents) completed a web-based survey
and attended focus group interviews.
Results
89 patients were recruited. Withdrawal rates were low at 4.5% (n=4). Forty-four patients 
(49.4%) completed ADNAT, leaving 45 (50.6%) non-completers. There were large baseline 
differences in HbA1c and variable rates of change at 6 months. After adjusting for baseline 
HbA1C and site in an Analysis of Covariance, completers had a lower post-ADNAT mean 
HbA1C level than non-completers at 6 months, suggesting improvement for those using 
ADNAT (95% CI -11.48, 0.64). Patients’ glycaemic control (HbA1c) at 6 months correlated 
reasonably well with their ADNAT scores (Spearman’s rho=0.46). Survey and focus group 
data showed that ADNAT was judged to be an effective clinical tool by the diabetes teams. 
Value to patients was perceived to be linked to parental support, age and previous diabetes 
education. The combined data triangulated suggesting validity of the study. It served to 
capture different dimensions which were used to define best practice standards and 
methodological recommendations including the need for a team based approach to 
implementation, broader patient-based outcomes, and non-participant clinic observations. 
Conclusions
The combined data showed that ADNAT was a clinically viable tool and that a future mixed 
methods, non-randomised, longitudinal cohort study would be feasible following MRC 
guidance for process evaluation of complex interventions, including use of the piloted logic 
model and the RE-AIM framework.
Trial registration
NIHR Children’s Clinical Research Network– UKCRN ID 6633
Keywords
Evaluation, Type 1 diabetes, needs assessment, questionnaire, patient education, glycaemic
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Introduction
This paper reports on a study which evaluated the use of the Adolescent Diabetes Needs 
Assessment Tool (ADNAT) App in three paediatric diabetes units (PDUs) in the North West 
of England. The study used a realist evaluation approach1 to address two issues: firstly, 
whether the ADNAT App could be integrated into paediatric diabetes care; and secondly to 
determine best practice standards and methodological recommendations for a future cohort 
study. A core assumption of a realist perspective is that phenomena such as ADNAT are 
complex interventions introduced into constantly changing systems, which has particular 
relevance to paediatric diabetes care in the UK. Comparisons within and between clinical 
sites were therefore required to determine what did and didn’t work and why, in order to 
establish local modifications necessary to ensure efficacy in practice. This relationship is 
expressed in MRC guidance2 for process evaluation of complex interventions which defines 
evaluation of context, implementation and mechanisms of implementation as the primary 
aims of such studies. 
Background
Type 1 diabetes (T1D) is one of the most common endocrine and metabolic conditions in 
childhood within Europe. The UK, which has 27,600 children and young people living with 
the condition, alongside the Russian Federation and Germany, make the largest contribution
to the overall numbers in T1D in young people cases is 31.1 per 100,000 aged 10-14 years 
versus 12.1 per 100,000 aged 0-4 years3,4. Alongside this, young people in the UK also have
one of the worst rates of glycaemic control in Europe, which is associated with later micro 
and macrovascular risk5. This has been demonstrated in successive National Paediatric 
Diabetes Audits (NPDA) for England and Wales for those aged 0-25 years, with the latest for
2014-154 reporting improving but still disturbing figures alongside the need to reduce 
variability in outcomes:
 Only 23.5% achieved recommended glycaemic targets of less than 58 mmol/mol, 
with 21.3% having levels above 80 putting them at high risk of complications. 
 Glycaemic variability is due to service related factors, including standards and 
delivery of diabetes self-care education which showed wide regional variability with 
only 50% overall receiving education.  
 Socio-economic factors strongly influenced outcomes - those in the most deprived 
areas have poorer blood glucose control, a higher risk of obesity and more 
microvascular changes in the kidney compared with those in the least deprived 
areas; and white ethnic groups achieved better control than other ethnicities.
 For those aged 12 years and over: 27.1% had high blood pressure, 21.8% had high 
cholesterol, over 11.6% had albuminurea (sign of kidney disease), over 12.8% had 
early signs of eye disease, and 20.7% i.e. 1 in 4 were obese.
 Overall, just 25.4% of children and young people received all 7 of the recommended 
key care processes including blood glucose (HbA1c), body mass index, blood 
pressure, urinary albumin, cholesterol, eye screening, and foot examination.
These findings have been supported by the UK’s National Peer Review Programme6 which 
highlighted inequity of service provision to young people. They also fit with the UK’s 
Kennedy Review7  which described teenagers as a ‘forgotten group’, reporting that their 
health care needs are given low priority by commissioners, policy makers and clinicians 
alike, and recommended investment in youth friendly services. This is particularly important 
for adolescents who can engage in behaviours which carry health risks, and many lack the 
skills and strategies to avoid them. This has particular relevance to those with diabetes given
their added risk of future debilitating complications.
In 2012 the UK Government responded to the problem by introducing a paediatric diabetes 
‘Best Practice Tariff’ (BPT) which specifies tailored education based on personal need as a 
mandatory care standard8. For adults, over a 10-year period, such education has been 
shown to save the National Health Service (NHS) £2,200 per patient, breaking even at four 
years9,10. No such data are available for young people, although Swift11 reported that 
education for young people has greater effects than for adults with small to medium effects 
on glycaemic control and larger effects on psychosocial outcomes. 
In the UK, six paediatric educational trial interventions have recently reported their results12-
16. They all followed traditional didactic face-to-face approaches, reported considerable 
variations in outcomes, and no significant long-term changes in glycaemic control. 
Recommendations included the need to review research methodology and to modernise 
paediatric care through the use of technology enhanced learning (TEL) to support long-term 
patient training. This latter recommendation is supported by a review of technology enabled 
approaches to diabetes management which endorsed self-assessment tools and tailored 
education based on patients’ unique histories and their immediate needs17.  In support of 
this, a meta-analysis of 46 studies found that a blend of TEL and face-to-face instruction had
stronger learning outcomes than did face-to-face instruction alone in 
primary/secondary/tertiary education18. However, there are few validated diabetes websites 
for young people, the majority being directed toward adults; there is wide variation in the 
quality of evidence provided, and they offer didactic information at high reading levels with 
little problem-solving assistance19.20. Social networking, as a patient-led tool, is growing in 
popularity and starting to be used by patients and practitioners but research in children with 
T1D in all these areas is lacking, both in terms of quantity and quality, reflecting the complex 
issues of using social media as a clinical tool21. Systematic reviews22,23, including our own24, 
have consistently highlighted an absence of rigorous UK based research, minimal use of 
theory, and no reporting of process, health inequalities, dose response and cost-
effectiveness data. In addition, findings highlighted the need to personalise learning in 
alignment with developmental stages i.e. age-related reasoning and cognitive abilities 
making regular needs assessment a core requirement. No instrument to assess such needs 
was located in the UK. We therefore developed, validated and psychometrically tested the 
ADNAT App. The App provides secure username and password protected access to ADNAT 
through mobile devices eg. smart phones and tablets, it delivers immediate feedback to 
users, and emails confidential patient data to practitioners. 
The ADNAT App 
Development, validation and psychometric testing of ADNAT have been reported 
elsewhere25-27. The research programme, followed Medical Research Council (MRC) 
guidance for complex interventions28. It has included studies of adolescent diabetes self-
care29-31 and technological methods of learning24, and theory32. ADNAT consists of 117 
questions divided between 6 domains including: all about me, physical activity, eating, 
monitoring blood glucose, medication taking and living with diabetes. Whilst the total number
of questions is large, the actual number answered by users is filtered according to, for 
example, insulin regimen and lifestyle factors. Thirty-six of the questions, hidden amongst 
the total number, provide two scored ‘Needs Assessment Ratings’ (NARs) relating to self-
care and psychosocial health. From our previous research26, ADNAT was theoretically 
determined to have the following mechanisms of action:
1. Mediator for facilitating tailored education and support by: raising patients’ self-
awareness about their diabetes self-care and coping mechanisms, identifying patient-led 
foci for conversation in the clinical consultation, and providing practitioners and patients 
with data to guide individual health care planning. 
2. Augmenting resource efficiency through: flexibility of access for patients and practitioners
using mobile phones and tablets, auto-saving function for ease of use by patients, large 
data storage capacity, and provision of ‘connected information’ for all members of the 
multidisciplinary team including patients. 
3. Strengthening professional accountability through: standardisation of needs assessment,
promotion of team working, and provision of educational audit data.
Based on these premises, ADNAT was included in the UK National Paediatric Diabetes 
Improvement Plan for 2013-201833. This inclusion stipulated the need to evaluate ADNAT’s 
use in clinical practice prior to long term implementation which proposed to follow a clinical 
efficacy and process evaluation route to support its on-going development. 
Aims and objectives
Paediatric diabetes clinical practice was (and still is) undergoing extensive changes. These 
changes have been instigated by the 13 BPT care standards8, alongside the annual National
Paediatric Diabetes Audit4, and a Peer Review Quality Assurance Programme6. These 
emerging changes meant that ‘routine care’ was neither standardised nor constant so that 
the outcomes of using ADNAT depended upon clinical context and health professionals’ 
responses to its implementation. This meant that the setting was a mediator of outcomes so 
that comparisons between PDUs was an important part of the evaluation study.
The MRC’s guidance for process evaluation of complex interventions2 identifies 3 areas for 
evaluation which are informed by the causal assumptions of the intervention, and 
interpretation of context, implementation, and mechanisms of implementation. This process 
evaluation model and the theories underpinning the intervention (experiential learning 
theories and the transtheoretical change cycle) guided the aims of the evaluation study 
which were to assess: (i) resources and processes that influenced implementation of 
ADNAT, and (ii) methodological issues in preparation for a large scale cohort study. A logic 
model was developed for the study based on this process model and is summarised in Table
1.
Table 1: ADNAT Logic Model 
INPUTS OUTPUTS OUTCOMES/IMPACT
Activity Participants/
Respondents
Pre-implementation Implementation Post-implementation
At 6 months  At 12 months At 18 months
 Staff 
training
 Technical 
support
 Research 
Nurses
 On-line 
assessment 
of patients’ 
needs using 
ADNAT
 Staff 
responses to 
patients’ 
identified 
needs 
 Patients 
(participants)
 Diabetes teams
(respondents)
Patients:
 Recruitment to study 
≥30% of PDUs’ 
populations aged 12-16 
years
 Baseline data collected
 No deterioration in mean 
HbA1c levels
Diabetes teams:
 mapping of NPDA 
historical data for each 
recruited site
 staff training completed
Patients:
 Response rates to ADNAT ≥50%
 Entry into behaviour change 
cycle reported
 Non-significant improvements in 
mean HbA1c levels.
Diabetes teams:
 zero data protection issues 
reported
 collaborating on use of ADNAT
 tailoring ADNAT to meet sites’ 
needs
 positive feedback on ADNAT’s 
efficacy including: system and 
information quality and 
accessibility
 intention to continue using 
ADNAT
Patients:
 Response rates >60%
 Changes in behaviour 
reported 
 Mean HbA1c levels 
significantly improving
Diabetes teams:
 zero data protection 
issues reported
 ADNAT normalised into 
team working
 positive feedback on 
ADNAT’s efficacy 
 intention to continue using 
ADNAT 
 using ADNAT as an Audit 
tool 
Internal Factors External Factors
Clinic and team structures/absorptive capacity for new
knowledge/receptive context for change
Socio-political climate/incentives and mandates/environmental stability/norm setting/peer opinion
Evaluation
Implement ADNAT            Collect data             Analyse and interpret data            Report
The objectives were defined using the RE-AIM framework, as recommended in MRC 
guidance34. RE-AIM stands for: reach, effectiveness, adoption, implementation, and 
maintenance and included the following: 
1. Reach: we assessed the number of participants recruited and retained, and response 
rates to ADNAT i.e. number completed divided by total number of recruits. Data were 
obtained from research nurses’ and patients’ ADNAT (monthly) data returns.
2. Effectiveness: we used NPDA data to assess (pre-study) the functional status of each 
site, a survey to measure site and practitioners’ views on ADNAT’s efficacy; and collected
pre/post glycated haemoglobin (HbA1c) data, taken from patients’ notes by the research 
nurses, to determine any changes in patients’ glycaemic control.
3. Adoption: we carried out a survey to assess system and information quality, accessibility,
social norms, data protection, and intention of PDUs to use ADNAT in the future. Focus 
group interviews explored resources needed to set up and sustain use of ADNAT, staff 
perceptions of factors affecting adoption, and their training needs.
4. Implementation/Maintenance: the survey and focus groups also explored staff responses
to working with ADNAT including perceived value and health improvement outcomes; 
and the focus group interviews looked at facilitators and barriers to use. 
Methods
The study was conducted between January 2013 and February 2015. Set up and delivery 
was supported by the Cheshire and Merseyside Children’s Clinical Research Network 
(CRN). This support included access to the NIHR CRN-funded research nurses in post at 
the three NHS Trust sites which were selected based on geography and positive responses 
to invitation letters. Ethics approval for the study was sought from the UK National Research 
Ethics Service (NRES) where it was defined as a service evaluation not requiring ethical 
review35 (see Additional file 1 for copy of letter). Approvals were received from all three sites 
based on the requirement that we used site files, information sheets, and consent/assent 
forms. The research team had no access to identifiable information for any patient 
consenting to use ADNAT. 
Participants
Young people with type 1 diabetes aged 12–18 years.
Respondents, sites and support
Respondents were health professional members of the diabetes teams including paediatric 
diabetes specialist: nurses, doctors, dieticians, and psychologists at three paediatric 
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diabetes centres in the North West of England. These 3 sites allowed the study to capture 
diversity of feedback data and ensured adequate representation based on information 
provided in the 2013-14 NPDA data (see Table 4). The approach to the implementation of 
ADNAT was tailored according to team dynamics but each site had a named research nurse 
for the study, and all members of the team were trained informally by HC to use ADNAT. On-
going support was provided by the on-site research nurses, and by the ADNAT technologist 
via email. Each site commenced at a different time point with Site 1 starting in March 2013, 
Site 2 in June 2013, and Site 3 in February 2014. 
Recruitment 
Recruitment was undertaken by the research nurses working in liaison with the diabetes 
teams to identify young people who met the inclusion/exclusion criteria, as shown in Table 2.
A letter of explanation and the study information sheet were posted to eligible young people 
who were later targeted at their clinic appointments. If they agreed to participate, those 
under 16 gave signed assent, whilst those over 16 years provided informed consent. Proxy 
consent of parents/guardians of young people under 16 was also obtained. All information 
sheets and consent forms were produced in age-and-stage-of-development appropriate 
formats, and were checked before use by an audit team at one of the participating sites. 
Copies of the signed assent/consent documentation were given to the young people and, 
where appropriate, their parent/guardian for their records; the original copy was filed in 
participants’ medical notes, and copies were kept in the site study files held by the research 
nurses. 
Table 2: Inclusion and exclusion criteria
Inclusion Criteria Exclusion Criteria
Type 1 Diabetes (T1D) ≥3 months post diagnosis Co-existing pathology e.g. cystic 
fibrosis 
Aged 12−18 years inclusive In receipt of prescribed medication 
likely to affect glycaemic control e.g.
systemic steroids
Able to give assent <16 years of age and informed 
consent >16 years
Have a diagnosed psychological or 
psychiatric disorder(s) that requires 
specialist treatment.  
Have parental/guardian consent for young people 
<16 years
Able to complete ADNAT
Have internet access at home, school, hospital, 
public library, or via mobile technology
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Delivery of ADNAT
Participants were provided by the research nurses with username and password access to 
the ADNAT App, alongside standard care based on the BPT8 criteria (3 monthly follow-up 
including HbA1c, and tailored self-care education; annual review of body mass index, blood 
pressure check and screening for eye and kidney problems from age 12, plus psychological 
assessment). The ADNAT App was accessed through the internet using a PC, laptop, or 
mobile technological devices including participants’ mobile phones or tablets. They could 
choose where to complete it: at home and/or in clinic on their own smart phones or using 
iPads loaned to them by the research nurses. All participants were followed up at their 
diabetes outpatient clinics or at a home visit. In both cases, the ADNAT outcome data was 
used to guide their health care plans. Those who successfully completed and submitted their
ADNAT questionnaires were called the ‘completers’, whilst those who chose not to submit 
were called the ‘non-completers’ and were used as the comparative group.
Quantitative outcome data 
A range of feasibility outcomes were measured including:
o ADNAT data to measure response rates across the PDUs. All data, which was 
automatically downloaded onto a secure central database, were encrypted to ensure 
anonymity. Data included: response rates and ADNAT NARs for self-care and psycho-
social health.
 National Paediatric Diabetes Audit data4 to assess the functional status of each site.
 Glycaemic control to compare pre/post intervention levels of glycaemic control using 
baseline HbA1c levels (means/standard deviations over previous 12 months), and 6 
month post ADNAT levels obtained from patients’ clinical notes by the research nurses. 
 A 67-item survey to collect information on adoption, implementation and maintenance. 
Adapted from a validated survey developed by Okazaki et al36, it has 7 domains 
including: system and information quality, accessibility, perceived value, data protection, 
health improvement, subjective norms, and intention to use in the future. We also 
included an open-ended question at the end asking if there was anything they would 
change. The survey was facilitated by the Audit Department at one of the participating 
sites using SNAP software (http://www.snapsurveys.com/), and was pilot tested by two 
researchers. It was sent out by the Audit Department via an email link to all respondents.
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Responses were returned directly to the Audit Department where analysis of the data 
was completed using SNAP software.  
Qualitative process evaluation data 
Three focus groups were run at the end of the study period, one at each of the 3 sites. All 
respondents were invited to participate and they were sent information sheets and an 
interview schedule prior to the meetings. The schedule was informed by the RE-AIM 
domains. Consent forms were signed prior to participation and to tape-recording the 
interviews. 
Data analysis
The encrypted quantitative ADNAT data were collated, coded and analysed using R or 
SPSS. All quantitative data taken from the ADNAT questionnaires were checked for missing 
or unusual values and for internal consistency of the scoring items. Participant glycaemic 
control (HbA1C) was monitored pre and post use of ADNAT at each site and across all sites 
using summary statistics for completers and non-completers. Analysis of covariance was 
performed with post HbA1C as the dependent variable; and baseline HbA1C, completer status 
and site as independent variables to assess whether any preliminary change in HbA1C levels 
was apparent. Correlations between high/moderate self-care needs (based on the self-care 
NAR) and poor/moderate levels of (pre-baseline and at 6 months) HbA1c were analysed 
using Spearman’s rho statistic37.  
Qualitative data were analysed using an inductive thematic content analysis, assisted by 
QSR NVivo software. First, an evolving set of themes was created and linked to 
respondents’ ‘quotes’. These themes were then categorised within the RE-AIM domains. To 
assure trustworthiness of the analysis, respondent validation was used by cross-checking 
findings with respondents and triangulating it with the quantitative outcomes. 
Results
Data from recruitment of patients, the NPDA, the survey and focus groups comprise the 
results of the study. The RE-AIM domains are used to present both the quantitative and the 
qualitative data.
12
1. Quantitative outcome data
Reach 
Figure 1 and Table 3 show recruitment rates and participant characteristic data. We planned 
to recruit a minimum of 80 patients and we recruited 89 in total, with an uptake of 65-70% of 
those who were screened as eligible to participate. The graph shows that actual recruitment 
rates were above our monthly anticipated target rates. Of those recruited, there were twice 
as many females to males and the withdrawal rate was low at 4.5% (n=4). Reasons for 
withdrawal included patient transfer to other areas (n=1), and not wanting to continue with 
the study (n=3). Forty-four young people (49.4%) submitted their completed ADNAT 
questionnaires. There were more female than male completers and non-completers (ratio ~1
male to 2 females), and their average age was 14.3 years compared to 14.5 years for the 
non-completers. 
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Figure 1: Recruitment rates: actual set against target rate (March 2013 - September 
2014)
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Table 3: Participant (patient) characteristics
Site 1 2 3 Combined
No. recruited 28 26 35 89
Male:Female ratio 8:20 10:16 12:23 30:59
Withdrawals (%) 0 3 (11.5%) 1 (2.9%) 4 (4.5%)
ADNAT Completers
N (†%) 13 (46.4%) 18 (73.1%) 13 (37.1%) 44 (49.4%)
Male:Female ratio 4:9 8:10 3:10 15:29
Mean age yrs. (range) 14.3 (12-16) 14.3 (12-17) 14.3 (12-16) 14.3
ADNAT non-Completers
N (†%) 15 (53.6%) 8 (30.8%) 22 (62.9%) 45 (50.6%)
Male:Female 4:11 1:3 9:13 1:2
Mean age yrs. (range) 14.6 (12-17) 15.3 (12-18) 14.1 (12-17) 14.5 
† Percentage of the number recruited
Effectiveness: Glycaemic Control
Data in Table 4 are taken from the 2013/14 NPDA4. It shows disparity between the sites for 
the percentage of young people who have a mean HbA1c of the recommended level of less 
than 58 mmol/mol (range 8.1% - 26.5%), with the mean (range: 65.5 – 78.7 mmol/mol) and 
median values (range: 64 – 78.7 mmol/mol) for all sites above the recommended level. The 
NPDA ascribes such variability (despite statistical adjustments for known confounding 
influences, such as ethnicity, social deprivation, gender, age and diabetes duration) to 
differences in service provision and delivery which has particular relevance for this study. In 
relation to this, care process records, which are used to monitor diabetes management and 
detect long-term complications at the earliest treatable stage, were also significantly different
in terms of incomplete records (range: 25.4 – 69.1%), again highlighting disparity between 
the three sites. Of note is the fact that the two with poorer HbA1c audit results (Sites 1 and 
3) had interruptions in team functioning during the study period due to staff changes and/or 
long term staff absences owing to sickness. 
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Table 4: Summary outcome data for the three study sites taken from the 2013-14 National
Paediatric Diabetes Audit
Site 1 2 3 
Total number of patients (aged 10-18 years) 248 (211) 110 (98) 121 (99)
HbA1c <58mmol/mol 
(normal HbA1c range = 20-41mmol/mol) 
16.6% 26.5% 8.1%
Mean HbA1c 72.4 65.5 78.7
Median HbA1c 69.0 64 74.0
% incomplete records of care processes (except 
HbA1c)
25.4% 40.7% 69.1%
Table 5 shows the glycaemic control data pre and 6 months post ADNAT for the completers 
versus the non-completers. For both groups subject-specific profile plots (not shown) and the
range of pre- and post-HbA1C levels, indicated that the young people had very different pre- 
glucose levels and variable rates of change leading to their post-HbA1C levels. Overall, 
summarising across all 3 sites, there was a non-significant reduction in the post ADNAT 
mean and median HbA1c levels for the completers, versus a non-significant increase in the 
mean and median levels for the non-completers. The mean HbA1C levels are illustrated in 
Figure 2 and suggest a potential decreasing trend in HbA1C for ADNAT completers. This 
trend is encouraging given that our Logic Model defined ‘no deterioration in HbA1c’ as the 
outcome at 6 months. 
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Table 5: Participant (patient) glycaemic control data pre/post-ADNAT
Summary measure Site 1 Site 2 Site 3 All sites
COMPLETERS
Pre-mean HbA1c 
mmol/mol (range)
73.1(22.4) 64.1(15.9) 74.6(14.7) 69.7(18.0)
Post-mean HbA1c 
(mmol/mol) (range)
63.1(12.6) 67.7(9.8) 75.9(21.7) 67.7(16.0)
Pre-median 65(43-119) 62(44-101) 71(56-104) 65(43-119)
Post-median 64(42-82) 61(55-90) 67(49-117) 65(42-117)
number pre ADNAT 13 19 13 45
number post ADNAT 13 15 13 41
NON-COMPLETERS
Pre-mean HbA1c 
mmol/mol (range)
78.9(21.0) 63.6(13.3) 68.8(18.8) 71.4(19.4) 
Post-mean HbA1c 
(mmol/mol) (range)
81.4(23.6) 63.7(13.2) 71.0(20.5) 73.4(21.3)
Pre-median 83(45-108) 69(42-83) 68(37-112) 69.5(37-112)
Post-median 80(40-122) 65(48-83) 71(40-130) 71(40-130)
number pre ADNAT 15 7 22 44
number post ADNAT 14 7 22 43
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Figure 2: Plot of pre and post mean HbA1C levels for completers and non-com
The results of the Analysis of Covariance (ANCOVA), presented in Table 6, show how post 
ADNAT mean HbA1C levels change after adjustment for pre-HbA1C, completer status and site.
In general the model explained a reasonable amount of the overall variability in post HbA1C 
levels with a R2 value of 0.52. Only pre-HbA1C mean level was a strong predictor of post 
HbA1C mean level (p<0.001), which is to be expected since the two measures are correlated.
On average post HbA1C levels increased by 0.71 mmol/mol for each unit increase in baseline
HbA1C. The completer status variable reached borderline significance (95% Confidence 
Interval -11.48, 0.64), indicating that on average completers had a post-ADNAT mean HbA1C 
level of 5.42 mmol/mol lower than non-completers. Mean differences between Site 2 and 
Site 3 compared to Site 1 indicated a lower average post HbA1C mean difference by 1.75 
17
mmol/mol at Site 2, and a higher average mean difference by 1.50 mmol/mol at Site 3, 
compared to Site 1, after adjusting for baseline HbA1C and completer status, but these 
differences were non-significant. Please note that the results from the above model should 
be interpreted with caution due to the small numbers at each site.
Table 6: ANCOVA regression analysis on Post-HbA1C levels
*Variable Estimate Std.Error 95% Confidence
Interval
Intercept 22.79 6.31 10.42, 35.16
Pre-HbA1c 0.71 0.08 0.55, 0.87
Completers -5.42 3.09 -11.48, 0.64
Site 2 -1.75 4.11 -9.80, 6.30
Site 3 1.50 3.92 -6.18, 9.18
*Reference categories are non-Completers and Site 1 
Figure 3 shows a scatter plot of the correlation between HbA1C level and self-care score. The
Spearman rho coefficient is 0.46 suggesting a good moderate correlation with higher (worse)
self-care scores indicating higher HbA1C levels overall. Only at one site was very little 
correlation observed due to several outlying young people with high HbA1C levels but 
generally lower self-care scores.
Figure 3: Scatterplot of HbA1C level and self-care total score at 6 months
18
All questions comprising the self-care score are listed in Table 7 together with the number of 
children and percentage scoring green, amber and red at each site using the ADNAT scoring
algorithm. The tables indicate that a large proportion of young people were scoring green for 
each item, indicating reasonable management, but box plots by item and site (not shown) 
suggested that there was variability across items and sites and that it was not necessarily 
the same group of young people scoring green across all items. It was noted that for 
Questions 66/71 that whilst there were amber and red counts listed, there were no green 
counts but instead blanks in the dataset. This identified a likely anomaly in the algorithm 
programming and these were recoded to green for the analysis as the most likely value. The 
anomaly is being investigated.
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Table 7: Summary of item scoring classificatons of 20 ADNAT self-care questons
Scoring algorithm summaries 
Count (%)
Domain Item No. Question Green Amber Red
Physical
Activity
16 How many hours of pulse-raising exercise or physical activity did you do last week 8 (18 %) 19 (42 %) 18 (40 %)
18 What stops or prevents you from starting to do exercise or physical activity 26 (58 %) 2 (4 %) 17 (38 %)
21 What makes it difficult to manage your blood glucose levels when exercising or doing 
physical activity
19 (42 %) 9 (20 %) 17 (38 %)
22 What usually happens to your blood glucose levels when you do exercise or physical activity? 23 (51 %) 15 (33 %) 7 (16 %)
Eating 34 Do you eat fruit and/or vegetables? 28 (62 %) 16 (36 %) 1 (2 %)
35 How many times a week do you eat treats, such as sweets, chocolate, fast food, takeaways? 20 (44 %) 15 (33 %) 10 (22 %)
38 Which statement best describes you? (diet control) 34 (76 %) 11 (24 %) 0 (0 %)
41 Which statement most applies to you? (carbohydrate calculation) 42 (93 %) 0 (0 %) 3 (7 %)
45 Are you happy with your weight? 19 (42 %) 12 (27 %) 14 (31 %)
Monitoring 
Blood 
Glucose
50 How often do you normally test your blood glucose in a day? 35 (78 %) 10 (22 %) 0 (0 %)
51 What motivates you to test your blood glucose? 40 (89 %) 5 (11 %) 0 (0 %)
53 How would you describe your blood glucose results? 20 (44 %) 21 (47 %) 4 (9 %)
57/62 How often do you have hypos/low blood glucose (less than 4 mmols/l) 
Have you been unconscious from hypoglycaemia in the last 12 months?
6 (13 %) 33 (73 %) 6 (13 %)
66/71 How often do you have high blood glucose (more than 10 mmols/l) 
Have you had diabetic ketoacidosis in the last 12 months (not including at diagnosis)?
24 (53 %) 5 (11 %) 16 (36 %)
76 What would you like your HbA1c to be? 39 (87 %) 0 (0 %) 6 (13%)
Medication 
Taking
80 What motivates you to do your injections or to give insulin through your pump? 30 (67 %) 14 (31 %) 1 (2 %)
Living with 
Diabetes
92 What would you do if you were ill with an infection (e.g. sickness/flu) and it made your blood 
glucose high?
38 (84 %) 1 (2 %) 6 (13 %)
94 You are staying over at your friend’s house. Which of the following would you do? 42 (93 %) 1 (2 %) 2 (4 %)
111 You are going to a party one Friday night with your friends and you know that they will be 
drinking alcohol.
 Which statement best describes what you would do?
37 (84 %) 4 (9 %) 3 (7 %)
112 Which statement best describes you? (diabetes and life) 13 (30 %) 24 (54) 7 (16 %)
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1.3 Survey
Eleven people (2 males, 9 females) completed and submitted the survey. They included 7 
nurses, 1 doctor, 2 dietitians, and 1 research nurse. When asked about years worked in 
paediatrics, two had worked for 5 or less years, two for 6-10 years, five for 11-20 years and 
two for 21-25 years. Two people had a recognised adult teaching certificate (English 
National Board 998 Adult Teaching and Assessing course) but no one had a paediatric 
teaching qualification. 
Adoption
Table 8 shows responses to statements relating to adoption of ADNAT which covered the 
following areas:
 Information and System quality: In relation to information quality, respondents gave a 
strong (74.5%) positive response to 5 statements suggesting confidence in ADNAT 
including its coverage of diabetes, although 12 responses (21%) indicated uncertainty. 
Overall, 79 out of 117 responses (68%) agreed or strongly agreed with the 13 statements
relating to system quality, 6 (5%) disagreed and 32 (27%) neither agreed nor disagreed. 
 Intention to use ADNAT in the future, accessibility and capability with technology: 
10 respondents (91%) said they intended to use ADNAT when it is available at their work
place. However, the majority (n=9) indicated that accessing Wi-Fi is a problem in their 
work place, and 4 people felt that their workplace is not good in the way it uses 
technology. Nine reported that patients had completed ADNAT at home, and five in clinic.
All respondents (100%) felt that ADNAT was secure with regard to data protection. When
asked about using technology in clinical practice, 9 respondents reported capability with 
computers, tablets and mobile devices, the remaining 2 were ambivalent (neither 
agreeing nor disagreeing). Out of 110 total responses, there were 51 positive replies 
(46%) relating to capability, with 9 people regarding technology to be an important 
element of their patients’ education. However, there was also ambivalence on 32 
occasions (29%). 
 Social norms (not shown in Table 7): when asked to give an opinion on whether their 
National Children and Young Peoples’ Diabetes Network, their managers, their 
colleagues, and their patients and their families would think they should be using ADNAT,
100% positively responded (n=11) to the Network and patients and families, and 63% 
(n=7) positively responded to the managers and colleagues options.
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Table 8: Responses to statements concerning system and information quality and intention to use ADNAT in the future
INFORMATION QUALITY: The information I obtained from ADNAT: Yes No Not sure
was easy to understand 9 2
was easy to interpret 8 1 2
included all necessary assessments 9 2
was sufficiently complete to meet my patients’ needs 7 4
had sufficient breadth and depth for my patients 8 1 2
Total 41 2 12
SYSTEM QUALITY Strongly
disagree
Disagree Neither agree
nor disagree
Agree Strongly
agree
Not
applicable
ADNAT is easy to use 1 6 3 1
ADNAT is equipped with useful features and functions 1 7 2 1
ADNAT is easy to complete 6 3 2
ADNAT is always available to use 1 3 5 1 1
ADNAT launches and runs right away 2 5 2 1 1
ADNAT does not crash 1 5 3 1 1
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ADNAT does not freeze after entering or retrieving information 1 4 4 1 1
The commands of ADNAT are well depicted by symbols and buttons 3 5 2 1
The layout of ADNAT is clear and consistent 1 6 3 1
The design of ADNAT is easy to use or operate 1 1 5 3 1
The Technologist showed a sincere interest in solving my problems 2 3 1 5
The Technologist gave me personal attention 3 2 1 5
The Technologist was dependable 3 2 1 5
Total 6 32 56 23 26
INTENTION TO USE IN THE FUTURE
Technology is an important element of my patients’ education 2 3 6
Without Technology I would be unable to do my work 3 2 6
Technology makes my work more enjoyable 1 7 1 2
My workplace is not good in the way it uses Technology 1 2 4 2 2
With Technology I interact more with my patients 3 2 4 2
I find using computers difficult 6 3 2
I find using technological devices difficult e.g. mobile phones, iPads 6 3 2
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Getting access to Wifi  is a problem in my work place 1 1 2 7
Technology makes my work easier 4 5 2
It would be good if Technology was used more 4 4 3
Total 14 13 32 28 23 0
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Implementation/Maintenance
Table 9 summarises survey responses to questions relating to implementation and 
maintenance of ADNAT which covered the following:
 Perceived value: overall, respondents judged ADNAT to be effective, practical, useful 
and efficient, with 68% (n=30 total responses) regarding it to be good or excellent, and 
nobody judging it to be poor. In relation to factors that influenced its value to patients, 
respondents were unsure about gender, insulin regimen, and hospital admissions, but 
confident with regard to parental support, age, and previous diabetes education. 
 Health improvement outcomes: statements here were based on the Transtheoretical 
Change cycle38. 96% (n=79 total responses) indicated that ADNAT had an effect at each 
of the eight different stages of the cycle with the majority (85%) indicating that effects 
happened sometimes, often or regularly. The ‘not applicable’ responses came from the 
research nurse who was not involved at the clinical level and were therefore not included
in the calculations.
When asked to add any comments about what they would change about ADNAT, 5 
responses were received including the need for iPads and improved Wi-Fi access in clinics, 
access to on-line reports, and inclusion of a section for patients to ask for immediate 
feedback/help from the diabetes team. 
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Table 9: Responses to statements concerning perceived value of ADNAT and health 
improvement outcomes
Statements Poor Fair Average Good Excellent
Perceived value of ADNAT in relation to:
Effectiveness 1 2 8
Practicality 2 4 5
Usefulness 1 8 2
Efficiency 4 6 1
Total 3 11 27 3
The value placed on ADNAT by my patients depended upon:
Yes No Not sure
Age 6 1 4
Gender 4 7
Reading and numeracy skills 6 5
Previous diabetes education 6 1 4
Parental support 8 3
Insulin regimen 4 7
Hospital admissions 4 7
No. of contacts with diabetes 
team
3 2 6
How frequently did ADNAT help your patients in relation to:
Never Seldom Sometimes Often Regularly Not
applicable
Enlisting help 3 6 1 1
Increasing knowledge about 
managing diabetes
1 6 2 1 1
Being aware of personal risks 1 8 0 1 1
Understanding benefits of 
changing behaviour(s)
1 8 1 1
Committing to changing 
behaviour(s)
1 8 1 1
Developing a plan for 
changing behaviour(s)
1 1 8 1
Changing behaviour(s) 1 8 1 1
Being aware of relapse 1 1 6 1 1 1
Total 3 9 58 4 8 6
1. Qualitative process evaluation data
Focus Groups
Each site and participant was coded (based on roles and numbers) for reference purposes 
as follows: Paediatric Diabetes Specialist Nurses (PDSN 1- 6), Doctors (Dr 1,2), Researcher 
(R 1,2), Psychologist (P), and Dietician (Di). 12 people in total attended the three groups 
providing a total of 124 minutes of recorded conversation. One individual interview of 36 
minutes was also completed (person was unable to attend the focus group), giving a total of 
160 minutes of recorded conversation. Analysis of the focus group data produced 7 sub-
themes which were aligned to the RE-AIM framework (themes). Findings are presented 
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using anonymised quotes to capture the essence of the phenomena, and are summarised in
the discussion. 
Adoption themes
 Tension for change
Respondents found ADNAT to be a viable option for clinical practice and wanted to change 
the way they engaged with their patients by using technology, recognising that web-based 
applications play a crucial role in adolescent life. They perceived technology as a way of 
overcoming communication barriers, as this nurse commented,
 “I remember being quite impressed at what they were saying they didn’t know. So it 
seems to get past that barrier when it is face to face. They are more likely to be honest 
even though they know we’re going to see it” (PDSN4).
 System fit
The 3 sites all felt that ADNAT fit within their team’s values and goals, with participants 
suggesting that it could standardise educational assessment allowing for comparisons 
between PDUs.  As a policy driver, the BPT enhanced motivation to use ADNAT, linking it to 
the education criteria. Other respondents agreed with this thinking suggesting that it also 
met with the peer review process but questioned its practical potential as an audit tool given 
that it assesses those aged 12-18 years only making it  “difficult to draw any conclusions” 
(Dr1). 
 Organisational working
Operationally, decision making regarding how to implement ADNAT was devolved to the 
teams to see what emerged. Two different methods were used:  individual nurses reviewing 
their own patient returns versus using a generic email for all returned questionnaires which 
was reviewed by one PDSN only. For the former, choice of treatment was determined by the 
individual nurses but they also discussed their approaches within their teams. For the latter, 
the PDSN identified urgent cases i.e. red traffic light returns for discussion at team meetings.
Both approaches therefore embraced working as a team, as the following quote highlights, 
“We did bring the red ones to the team meeting and there were actions..generated from 
it, and we did implement those actions. I think the ones that came through green 
reinforced what we felt but it was good to get the teenagers’ perspectives married up 
with ours” (PDSN2).
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 Team working
Team capacity varied owing to sickness absence and/or new staff starting. Site 2 was not 
affected by these problems and had an established team. It was notable that this site had 
the best 2013/14 audit returns in relation to glycaemic control (as highlighted in Table 4) and 
also the best ADNAT return rates (73.1%), compared with the other two sites (46.4% and 
37.1%). With regard to team working, participants commented on how ADNAT encouraged a
standardised approach which supported consistency in the messages given to patients. 
They argued that integrating ADNAT into their team work would normalise its use, although 
lack of time, given the current politically driven changes, had impacted upon feelings of 
being in control. Respondents talked about “time constraints”, “feeling too busy”, and “a 
continual focus on problems”. Receptivity for change therefore varied across the sites 
although respondents felt that ADNAT had the potential to drive change.
Implementation/Maintenance themes
 Time
The time taken for patients to complete ADNAT was discussed given the large number of 
questions to be answered but two respondents had asked patients for their perspectives and
both reported positive responses,
“I asked quite a few of them, was it a waste of 30 minutes of their life and they all 
said ‘no’ they felt it was useful that they’d done it, and many of them said it made 
them think…” (Dr2)
“..a lot of them came back and said it was a good use of their time and gave them 
that refreshment of the advice that we gave them previously” (PDSN6).
For the practitioners, the time taken to review patients’ outcome results was helped by 
ADNAT’s scoring and traffic light feedback systems, alongside the drop-down menus and 
navigation commands to allow selection of scoring questions only, and/or questions relating 
to the different domains. However, when asked whether they felt the traffic light system was 
good for the children, there was a mixed response. It was viewed as both a facilitator and a 
barrier, with the barrier relating to its potential to raise young peoples’ anxiety.
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 Embedding ADNAT into practice
There were mixed responses with regard to where ADNAT should be completed. Location 
was seen as important affecting both uptake and practitioner feedback to patients. Home 
completions brought problems in relation to patients being willing to complete it once they 
left clinic, and time between completion and feedback was deemed important, as the 
following quote highlights,
 
“Because they did it at home and sometimes then a week after their previous clinic 
appointment, then it would be reviewing it again much later. …and actually they 
couldn’t remember the results” (PDSN4) 
Theoretically, completions in clinic prior to their consultation were thought beneficial but 
practically this was not an option given time limitations. Home visits were appropriate for two 
of the sites but at the third site, home visits were being discouraged by management. These 
comments highlighted a barrier to embedding ADNAT into practice. When questioned about 
how this could be overcome, integrating ADNAT into patients’ health care plans was seen as 
a viable option, with patients completing ADNAT prior to their next clinic appointment at 
home. Suggestions included gaining consents in clinic, sending instructions on how to 
complete ADNAT with their clinic appointment letters, followed by text reminders. The role of 
the lead clinician was seen as crucial for embedding ADNAT into routine practice, alongside 
mandating its use through, for example, including it in the BPT criteria. Tailoring ADNAT to fit
each site was seen as important, paying attention to the whole team being involved. To meet
this goal, training (up to a maximum of 4 hours) was considered essential. Web based 
instruction was not popular given the need for self-motivation and personal time, but face-to-
face training was deemed superior in that it would, 
“ ..help to promote the team aspect of it because discussion could be had about how 
to make it cohesive as a team” (PDSN4). 
Another suggestion was to include previous users of ADNAT i.e. expert patients in the 
training programme. 
 Linkages 
Respondents felt that ADNAT mapped on to what they are aiming to achieve in clinic 
including getting patients to “create (their own) agendas and identify things” (P). Other 
respondents felt that it provided the link between all the different components of diabetes 
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self-management commenting that ADNAT got patients “thinking about aspects of the 
condition which they might normally not really think about” (PDSN 3). There were comments 
that in clinic the focus tends to be on blood glucose and insulin doses whilst ADNAT 
promoted reflection on all aspects of their diabetes, including their feelings. One person 
summarised ADNAT’s perceived value in the following way,
 “the opportunity for self-evaluation of learning, reflection, and for young people to 
actually get feedback on what they know, and also for the teams to have feedback on
what they know as young people” (Di). 
This process of self-evaluation was a strong theme throughout the focus groups with one 
nurse commenting that ADNAT, “…reminded them (patients) about the right ways to manage
their diabetes” (PDSN6). There was agreement that ADNAT promotes behaviour change and
in terms of why it is effective, one person summarised her opinion by saying that, 
“It gives them (patients) a chance to identify. They’re doing the identifying, possibly 
prioritising things for themselves …and if it has come from them, then they are much 
more likely to engage in conversations about what could be done differently….” (P)
Respondents questioned the primary (misplaced) focus on glycaemic control with one 
person stating that education is more about quality of life at this age, and being able to, 
“… get a balance between their diabetes and being a teenager..”. (PDSN4). This point was 
agreed by others who felt that a single educational intervention is not going to impact upon 
glycaemic control because there are “’an awful lot of things that affect someone’s HbA1c’ 
(Dr.2). Education was seen as beneficial in other ways including improving quality of life and 
self-care processes and the example of carrying glucose to treat hypoglycaemia was used to
highlight this point.
Having open-ended text responses at the end of each question was seen as important, 
because it allowed patients to express their feelings of knowing more and being in control. 
This concept of ‘control’ was an important theme, with ADNAT being viewed as a way of 
accessing patients’ needs without removing their sense of control, as the following quote 
highlights,
 “..it might be a question that they (patients) might not have thought about, but felt a 
bit embarrassed, or thought well, I shouldn’t think like that, or maybe other people 
don’t feel or think like that,  I should know that.” (PDSN3)
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Accessing patients’ needs meant that the teams could tailor conversations with their 
patients, focusing in on their raised self-awareness with regard to what they did and didn’t 
know, providing a base on which to progress joint health care planning 
Discussion 
This evaluation study aimed to assess resources and processes that influence 
implementation of ADNAT taking into account context and impact. It also aimed to determine
methodological recommendations for a future large-scale cohort study. A logic model was 
developed and research objectives were defined using the RE-AIM framework. Based on the
quantitative outcome results and the qualitative process evaluation findings, a number of 
practice and methodological implications can be determined as follows: 
Practice implications
Table 10 provides a summary of the quantitative results and the qualitative findings and 
shows that from a quantitative (reach and effectiveness) outcomes perspective, ADNAT met 
the proposed mechanisms of action and the short-term objectives, as defined in the Logic 
Model. The survey and qualitative findings indicate that ADNAT was acceptable for adoption 
by the diabetes teams and by their patients. Findings from the qualitative data supported the
following recommendations for the successful use of ADNAT:
 Reach: to ensure uptake, a lead clinician’s support is essential alongside a team 
approach to foster integration, normalisation and consistency in the messages given to 
patients and their carers. 
 Adoption:  to support adoption, access to technical support and iPads with SIM cards to
overcome Wi-Fi problems in clinics is required, alongside training using an activity style 
of learning and limited to a maximum of 4 hours, to support team working and the 
tailoring of ADNAT to fit each team. Including patients in the training will provide insight 
into their experiences of using ADNAT supporting the connection between theory and 
practice. 
 Implementation/Maintenance: to promote implementation, a short time span is needed 
between patients’ completions of ADNAT and follow-up reviews. To support this, 
consents can be taken in clinic, followed by instructions at a later date in patients’ 
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appointment letters. ADNAT can then be completed at home prior to their clinic 
consultation, supported by automatic text reminders. 
 ADNAT requires a section for patients to ask for immediate feedback/help from diabetes 
teams, and also to short on-line reports i.e. ADNAT profiles for each patient for 
practitioners. Patients’ potential negative responses to the traffic light feedback system 
also need to be addressed by using a less threatening feedback response. 
 NPDA data for the three sites in Table 4 show that 85% of their total population is aged 
10-18 years which suggests that use of ADNAT as an audit tool is a viable option.
Methodological implications: Strengths and limitations
 A strength of this study lies in its mixed methods design and the fact that there was 
overlap between the data sets. This means that there is less probability of drawing 
erroneous conclusions and serves to validate the findings from each method. It also 
helps to explain outcomes to provide a frame for application of the results. Findings 
therefore provided an insight into ADNAT’s potential in relation to glycaemic control 
(HbA1c), particularly for those poorly controlled. It also raised issues regarding the 
wording of 2 questions. We therefore trialled changing the wording and re-calculating the
correlations which showed small improvements suggesting that the changes were viable.
 A limitation of this study is the small number of sites, participants and respondents 
involved raising statistical issues concerning the accuracy of the outcome data. We are 
therefore seeking funding for a large scale study across many PDUs in Northern 
England. 
 Another limitation relates to the number of young people who completed the ADNAT 
questionnaires. Whilst the percentage of completers (49.4%) is good in terms of figures 
quoted for the response rate of the general population to web based surveys (24.8%)39, it
remains questionable as to how typical the completers were relative to the non-
completers and to those who declined to participate. Reasons why young people choose
to engage or not in using ADNAT therefore need to be researched to improve response 
rates.
 The research setting is a mediator of outcomes so that a limiting factor is the problem of 
treatment heterogeneity. Whilst ADNAT is a standardised intervention, the responses of 
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the teams to the outcomes of using ADNAT are heterogeneous. In addition, no member 
of the diabetes teams involved in the study had training in paediatric education. This 
demonstrates a need to include non-participant clinic observations to evaluate 
educational capability amongst the diabetes teams. It also validates the need to research
comparative effectiveness to provide evidence on the benefits and harms of different 
response options. This will have wider benefits in terms of recommendations for 
educational and practice related training.
 The recruitment and non-allocation procedures maintained comparable groups to ensure
internal validity. It allowed access to ADNAT by all participants, overcoming ethical issues
of withholding treatment. Also the problems of cross-contamination within and between 
sites, particularly relevant where ADNAT is concerned given its novelty potentially 
creating motivations to access ADNAT by sharing usernames/passwords via social 
networking etc., which is relevant to this age group, and the fact that information is 
publicly available via the web and in publications.
 For those who did choose to take part, it could be presumed that they wanted a different 
kind of management for their diabetes, one that fits more effectively with their digital 
culture and their learning styles. This has implications for the results of the evaluation 
because it suggests that some of the participants were ready to make changes. Using a 
non-randomised design (completers versus non-completers) will overcome the ethical 
issues noted above. Such a study needs to cover longer term outcomes and processes 
i.e. beyond 12 months, as defined in the Logic Model. The fact that ADNAT offers a 
tailored, reinforcing, long term approach to education, which is different to education 
programmes that have been trialled previously, reinforces this fact. 
 Previous research has highlighted the need for adult diabetes education to have broad 
patient-based outcomes, and not to be expected to have lasting benefits on glycaemic 
control unless it is repeated39. The focus group data reinforced these points highlighting 
the need to include other outcomes such as quality of life and patients’ greater self-
involvement in their care. Findings from previous trials of paediatric diabetes education 
have also affirmed this point15. Measures of effectiveness therefore need to include but 
not be limited to glycaemic control.
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Table 10: Summary of data sets
RE-AIM THEMES OUTCOMES
(Patients)
SURVEY
(Diabetes Team)
FOCUS GROUPS
(Diabetes Team)
Reach  Uptake better than expected (n=89)
 Twice as many females to males 
recruited 
 Low accrual rates (n=4)
 Response rates 49.4% 
 Average age of completers & non-
completers 14.3/14.5 years respectively
 More female than male completers: ratio
~1:2 
 All reported technological capability in
clinical practice
 Some ambivalence re: using 
technology in patients’ education
 No paediatric teaching qualifications
 Ideal time to integrate ADNAT into clinical practice
 Offers a technological approach to care in line with 
policy and young peoples’ needs
 Fits within BPT’s education criterion/peer review 
process.
 Potential as an audit tool questioned given its focus 
on 12-18 yrs only. 
 Training to use activity learning to support a team 
approach and include expert users of ADNAT
Effectiveness  Completers - post-ADNAT mean HbA1C 
level 5.42 mmol/mol’s lower than non-
completers at 6 months, suggesting 
change was apparent.
 ADNAT judged to be effective at each of 
the 8 different stages of the 
transtheoretical change cycle.
 ADNAT’s system and information 
quality judged as good 
 ADNAT judged to be effective, 
practical, useful and efficient
 Value to patients perceived to be 
linked to parental support, age and 
previous diabetes education.
 Time between patients’ completions and reviews 
with practitioners in clinic/home critical to 
effectiveness.
 ADNAT perceived to promote behaviour change
 Primary outcomes to include glycaemic control and 
quality of life, with qualitative data to illuminate wider
effects of education  
Adoption  Majority of patients completed ADNAT
in clinic
 All felt that patients, their families and 
the Diabetes Network would want 
ADNAT to be used
 Majority intend to use ADNAT in the 
future
 Lead clinician‘s support essential 
 Requires a team approach to implementation
 Needs to be tailored to fit each team 
 Scoring, traffic light feedback, drop-down menus and
navigation commands support tailored health care 
planning but some concern re: patients’ responses to
traffic light system 
Implementation/ 
Maintenance
 Access to Wi-Fi in clinics 
poor/negligible
 No data protection issues reported
 Need for:
o improved Wi-Fi access and 
IPads
o Section for patients to ask 
for immediate feedback/help 
from diabetes teams
o Access to short on-line 
patient reports
 Access to on-line technical support needed
 Use of Ipads with SIM cards to overcome Wi-Fi 
problems in clinics
 To secure clinical feasibility: 
o home completions prior to clinic visits
o consents taken in clinic
o instructions sent in appointment letters
o automatic text reminders.  
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CONCLUSIONS
This evaluation study addresses the question of whether the diabetes teams and patients 
would accept ADNAT as part of the diabetes health care process. It also provided 
methodological information for future research. Having the non-completers as a comparative
control group minimised type 1 errors given that patient groups (and practitioners) had 
access to the same processes of care including training in how to use ADNAT. The 
evaluation demonstrated a number of limitations which have provided practice and 
methodological guidance. It has shown that a future mixed methods non-randomised 
interventional longitudinal cohort study would be feasible following MRC guidance for 
process evaluation of complex interventions, including use of the logic model and the RE-
AIM framework. 
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